SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
466Rigel in pact with AstraZeneca for arthritis drug * Signs worldwide license deascaram(o)uche-2/16/2010
465<i> Lilly already made their announcement. Smartest thing for a rigl suitomopgcw-1/17/2010
464Lilly already made their announcement. Smartest thing for a rigl suitor to do iscaram(o)uche-1/16/2010
463FWIW, CS figures first half of this year for the announcement.mopgcw-1/16/2010
462Some analysts think Rigel will sign a partnership this year. It would be interetuck-1/6/2010
461Potential safety issue for R788 I used to own and be bullish on RIGL, but this mcbio-1/5/2010
460barrons: Rigel Pharma Gives Up Gains. By Greg Bartalos Boutique drug developer mopgcw-12/21/2009
459I think I have seen this model for nephrotoxic serum nephritis before. I donkenhott-12/7/2009
458[A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerultuck-12/5/2009
457Rigel Announces Third Quarter 2009 Financial Results Press Release Source: Rigemopgcw-11/3/2009
456Rigel Pharmaceuticals Inc. (RIGL) said Thursday it will sell at least 13 millionmopgcw-9/18/2009
455Rigel Announces Second Quarter 2009 Financial Results PR Newswire - Tuesday 08/0mopgcw-8/8/2009
454CS: Rigel Pharmaceuticals Inc. (RIGL) OUTPERFORM [V] M. Aberman CP: US$ 8.42 TP:mopgcw-8/5/2009
453<reply> I am not predicting a $25m/20% deal, just asking the question in kenhott-7/30/2009
452Seeking Alpha: Rigel Pharma: The Importance of Knowing Your Stock 2 comments by:mopgcw17/29/2009
451CS: Rigel Pharmaceuticals Inc. (RIGL) OUTPERFORM [V] M. Aberman CP: US$ 11.56 TPmopgcw-7/24/2009
450I didn't listen to the conference call yet. But I will try to when I get a kenhott-7/24/2009
449How bizarre is this?? The objective components are statisticall significant, bumopgcw-7/23/2009
448Taski3 failed. No love for RIGL after all. Somebody knew something before handkenhott-7/23/2009
447[R763 Aurora Kinase Inhibitor: Preclinical characterization] J Cancer Res Clintuck-7/20/2009
446CS: Rigel Pharmaceuticals Inc. (RIGL) OUTPERFORM [V] M. Aberman CP: US$ 11.24 TPmopgcw-7/10/2009
445What, no love for RIGL either? I guess at least some love from the market. Stokenhott-7/9/2009
444Rodman and Renshaw like it and give RIGL a generous target price; <i>AnalSteve Lokness-6/9/2009
443Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers PR Newswire - Momopgcw-6/1/2009
442citi: Rigel Pharmaceuticals Inc (RIGL) Non-eventful 1Q09- All Eyes on Phase IIb mopgcw-5/23/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News